DONZAKIMIG
UNII H239R928TY

Substance Identification & Data

This profile provides standardized clinical and technical data for Donzakimig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H239R928TY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2765066-99-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

H239R928TY

CAS Registry Number

2765066-99-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DONZAKIMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203155

National Cancer Institute reference terminology for clinical and research data.

INN ID

12679

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-171

Identifier assigned by the United States Adopted Names Council.

Substance Type

Donzakimig

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Donzakimig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Donzakimig

Common Names & Synonyms

DONZAKIMIG [USAN]

Fused G1(VH-CH1-h)-scFv heavy-kappa heavy chain humanized (1-486) [G1(VH-CH1-h) anti-IL22 humanized (1-222) [VH (Homo sapiens IGHV3-23*04 (83.7%) -(IGHD) -IGHJ5*02 (100%), CDR-IMGT [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo sapiens IGHG1*01 CH1-h, G1m17 (CH1 K120 (216) (120-217), hinge 1-5 (218-222)) (120-222)] -11-mer seryl-bis(tetraglycyl-seryl) linker (223-233) -scFv heavy-kappa anti-ALB humanized, scFv-v1 C49 (VH)-C120 (VL) (234-486) [VH (Homo sapiens IGHV3-23*01 (78.6%) -(IGHD) -IGHJ2*01 (93.3%) C49 (277), R120>Q (346) (CDR-IMGT [8.7.15] (259-266.284-290.329-343)) (234-354) -20-mer tetrakis(tetraglycyl-seryl) linker (355-374) -V-KAPPA (Homo sapiens IGKV1-12*01 (86.5%) -IGKJ1*01 (90.9%) C120 (477), CDR-IMGT [7.3.11] (401-407.425-427.464-474)) (375-486)]] and fused L-kappa-scFv heavy-kappa light chain humanized (1'-474') [L-KAPPA anti-IL22 humanized (1'-219') [V-KAPPA (Homo sapiens IGKV1-9*03 (89.8%) -IGKJ4*01 (100%), CDR-IMGT [6.3.14] (27'-32'.50'-52'.89'-102')) (1'-112') -Homo sapiens IGKC*01 (100%), Km3, A45.1 (158'), V101(196') (113'-219')] -11-mer seryl-bis(tetraglycyl-seryl) linker (220'-230') - scFv heavy-kappa anti-IL13 humanized, scFv-1 C49 (VH)-C120 (VL) (231'-474') [VH (Homo sapiens IGHV1-69*08 (81.6%) -(IGHD) -IGHJ1*01(100%), C49 (274), CDR-IMGT [8.8.9] (256'-263'.281'-288'.327'-335'))(231'-346') -20-mer tetrakis(tetraglycyl-seryl) linker (347'-366') -V-KAPPA(Homo sapiens IGKV1-NL1*01 (83.9%) -IGKJ2*01 (91.7%) C120 (465'), CDR-IMGT [6.3.8] (393'-398'.416'-418'.455'-462')) (367'-474')]]; produced in Chinese hamster ovary (CHO) cells, cell line CHO-DG44

Immunoglobulin G1, anti-(human interleukin 22) (human-Oryctolagus cuniculus γ1-chain N-terminal fragment) fusion protein with peptide linker (SGGGGSGGGGS) fusion protein with immunoglobulin anti-(human serum albumin) (human-Oryctolagus cuniculus singl...

donzakimig [INN]

mmunoglobulin G1(VH-CH1-h)-scFv_L-kappa-scFv, anti-[Homo sapiens IL22 (interleukin 22, IL-22, ILTIF, IL-TIF)], anti-[Homo sapiens IL13 (interleukin 13, IL-13)] and anti-[Homo sapiens ALB (albumin, human serum albumin, HAS)], humanized, trispecific, trivalent

Technical Codes

UCB-1381

UCB1381

External Clinical & Regulatory Resources

Previous UNIIH235ZT33OD

Next UNIIH23CZQ62HC